Albuquerque, New Mexico, October 15, 2014,OCO Biomedical, Inc.
As a highlight to the American Academy of Implant Dentistry’s (AAID) program theme, “New Trends, Techniques & Technology – Innovations in Implant Dentistry,” OCO Chief Operating Officer and Director of Education and Clinical Affairs, Charles Schlesinger, DDS, FICOI, will present “The Next Generation of Dental Implant Technology: The Reality of Osseous Fixation,” on Wednesday, November 5, from 9:00-9:20 am at the 2014 AAID Educational Conference to be held at the Hyatt Regency Orlando, 9801 International Drive, Orlando, FL, 32819.
Dr. Schlesinger’s lecture will cover the impact of osseous fixation and implant choice and how this process expedites immediate-loading capabilities, which allows practitioners to predictably restore an implant in a short period of time.
In addition to Dr. Schlesinger’s lecture, OCO Biomedical Inc., a proven global leader in implant dentistry products, technology and training will showcase “The OCO Advantage: A Complete Dental Implant Solutions Approach” featuring the Company’s updated product line and innovations in technology. Information about the expanded AGD-Pace accredited 2014-15 educational courses, workshops and registration discounts for AAID participants to the upcoming 2015 OCO Biomedical International Implant Symposium will also be available. Official exhibition hours are Thursday, November 6, from 9:30 am – 7:00 pm, Friday, November 7, from 9:30 am – 5:00 pm and Saturday, November 8, from 9:30 am –1:00 pm.
“OCO Biomedical has always emphasized the critical importance of continuing education for practitioners to improve patient care and build practice performance. Over the years, based on our constant research and assessment of the ever-evolving needs of the dental community, and, given the fact that implant dentistry is now one of the fastest growing segments within the industry, OCO remains totally committed to providing practitioners with cutting-edge product, technology and training excellence essential to success in this very competitive field,” states Schlesinger. “OCO’s entire program is designed by dentists for dentists. We look forward to sharing our exciting, new developments again this year with our many AAID colleagues and associates.”
In addition to OCO’s lecture and exhibition, the Company has announced that Dr. Schlesinger and OCO Biomedical’s Founder and President, David D. Dalise, DDS, will be available for mentoring and consultation as schedules permit.
For further information, call OCO Biomedical at or visitwww.ocobiomedical.com. Printed OCO Product Catalogs available upon request.